August 27, 2024
Aganitha cognitive solutions private limited
Pharma and Biotech R&D
Aganitha’s AI powered in silico platform & solutions accelerate disease studies, target identification, de novo discovery and optimization of therapeutics (small molecules, antibodies, RNA, peptides, cell and gene therapies), synthesis modeling and optimization, for global biopharma and innovative biotechs.
Sector:
B2B
Founder Name:
Prasad Chodavarapu
Prasad Chodavarapu
Founding Year :
5/18/2017
5/18/2017
Website :
https://www.aganitha.ai
https://www.aganitha.ai
Overview
1. Disease studies to identify new targets, uncover mechanisms of action and stratify patient populations using the power of: – Single cell multi-Omics (scRNA-seq, Proteomics, Spatial Omics, Epigenomics …), – Whole genome sequencing (WGS) and Proteogenomics – High-throughput pre-clinical experimentation datasets
2. De novo design, characterization and optimization of therapeutic candidates in silico using computational omics and chemistry models and AI. E.g.: – Antibody engineering, – RNA design and optimization, – Viral Vector optimization for advanced cell and gene therapies
3. Analysis and optimization of bio-synthesis reactions using the power of AI/ML and computational modelling of underlying cellular processes.
Team:
58